tion. One of his 2 sons also had ASD and exhibited AV block at the age of 10. He too had had surgical ASD closure and permanent pacemaker implantation, but died at the age of 18 due to pneumonia (Fig 2) . In order to examine whether a point mutation in CSX/NKX2-5 was associated with this case of familial ASD, we extracted genomic DNA from the whole blood of the 59-year-old patient and determined the sequence of the entire coding region of CSX/NKX2-5. Sequence analysis revealed a C to T transversion at nucleotide 701 in one allele (Fig 3) , resulting in the production of a carboxy-terminal truncated protein due to the nonsense mutation at amino acid 198.
Discussion
Three types of point mutations in CSX/NKX2-5 have been reported in 4 big ASD families. 5 All mutations are situated in or just after the homeodomain. 5 The mutation in Jpn Circ J 1999; 63: 425 -426 (Received February 8, 1999 ; revised manuscript received March 8, 1999; accepted March 11, 1999 88 s) , which implies the coexistence of intermittent AV block. The phonocardiogram at 3L before atrial septal defect closure shows the widely split and fixed second heart sound and a systolic ejection murmur due to a relative pulmonary stenosis. the present case is the same as one of these 3 mutations and exists just after the homeodomain. The truncation in the carboxy-terminal sequences outside the homeodomain is thought to result in activation of CSX/NKX2-5 due to the production of an activating mutant. 9 In contrast, the other 2 mutations in the homeodomain are thought to cause CSX/NKX2-5 haplo-insufficiency due to the change in the DNA-binding affinity or the sequence specificity of the homeodomain. In this respect, there is an apparent paradox in the pathophysiological nature of the ASD caused by CSX/NKX2-5 mutations. Both partial hyperactivation and inactivation of the function of the CSX/NKX2-5 protein result in the failure of atrial septum formation. In addition, no ASD or AV conduction abnormalities have been reported in mice heterozygous for the Csx/Nkx2-5 null allele. 8 Therefore, the precise molecular mechanisms by which these mutations in CSX/NKX2-5 cause ASD awaits further detailed analysis.
It has been reported that all the affected patients with CSX/NKX2-5 mutations have AV conduction abnormalities. 5 They exhibit progressive electrophysiological abnormalities and a high incidence of sudden death or pacemaker implantation even after surgical correction of the ASD. 5 Our proband and his son also showed AV conduction abnormalities (Fig 2) , which suggest the critical role of CSX/NKX2-5 in the physiological function of the AV conduction system in the adult. Although the precise function of CSX/NKX2-5 in the maintenance of normal AV conduction is unknown at present, the fact that the electrophysiological properties of AV nodal cells are similar to those of embryonic cardiomyocytes may suggest a possible relationship between AV nodal dysfunction and impaired cardiomyocyte differentiation due to CSX/NKX2-5 mutations. The identification of CSX/NKX2-5 mutations in familial ASD patients is, therefore, of practical importance in that the existence of such mutations may predict the risk of sudden cardiac death and the requirement for pacemaker implantation.
In summary, we have identified the first case of familial ASD with AV conduction abnormalities associated with a point mutation in CSX/NKX2-5 in a Japanese patient. Further cumulative information regarding the CSX/NKX2-5 mutations that cause familial ASD will elucidate both the pathological nature of congenital heart diseases and the genetic basis of heart development. 
